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Summary
Mutations in the store-operated Ca2+ entry pore protein ORAI1 have been reported to cause myopathies in human patients but the
mechanism involved is not known. Cardiomyocytes express ORAI1 but its role in heart function is also unknown. Using reverse genetics
in zebrafish, we demonstrated that inactivation of the highly conserved zebrafish orthologue of ORAI1 resulted in severe heart failure,
reduced ventricular systolic function, bradycardia and skeletal muscle weakness. Electron microscopy of Orai1-deficient myocytes
revealed progressive skeletal muscle instability with loss of myofiber integrity and ultrastructural abnormalities of the z-disc in both
skeletal and cardiac muscle. Isolated Orai1-deficient cardiomyocytes showed loss of the calcineurin-associated protein calsarcin from
the z-discs. Furthermore, we found mechanosignal transduction was affected in Orai1-depleted hearts, indicating an essential role for
ORAI1 in establishing the cardiac signaling transduction machinery at the z-disc. Our findings identify ORAI1 as an important regulator
of cardiac and skeletal muscle function and provide evidence linking ORAI1-mediated calcium signaling to sarcomere integrity and
cardiomyocyte function.
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Introduction
Calcium signaling plays a fundamental role in muscle cells,
including regulation of growth and differentiation, metabolism
and gene expression. In addition, altered calcium signaling plays
an important role in the pathophysiology of cardiac diseases such
as myocardial infarction and pathological hypertrophy. Ca2+-
release-activated Ca2+ entry (CRAC) is a established mechanism
for nonexcitable cells to replenish intracellular calcium stores and
for subsequent Ca2+-dependent signaling cascades (Feske, 2007).
Calcium-release-activated calcium channel protein 1 (ORAI1),
the calcium-selective pore that mediates CRAC current (Prakriya
et al., 2006; Vig et al., 2006), was shown to be expressed in
isolated cardiac myocytes and is an important regulator involved
in hypertrophic growth in neonatal cardiomyocytes (Voelkers
et al., 2010). ORAI1 mutations or deficiencies cause myopathy
(McCarl et al., 2009). ORAI1-deficient mice die of unknown
cause shortly after birth, and the role of ORAI1 in intact hearts is
unknown (Gwack et al., 2008; Vig et al., 2008). To examine the
role of ORAI1 in the intact heart in vivo, we used reverse
genetics in zebrafish, an intriguing model organism for
evaluating effects of gene loss on cardiovascular function
(Hassel et al., 2009; Nasevicius and Ekker, 2000; Rottbauer
et al., 2005; Sehnert et al., 2002), because the absence of blood
flow for several days does not affect development of other organs
(Shin and Fishman, 2002). We provide evidence that Ca2+ entry
through ORAI1 is necessary to maintain sarcomere integrity and
establish proper z-disc function, in part through regulation of the
localization of the calcineurin-associated protein calsarcin. Our
results have identified a mechanism by which excitable cells
spatially control Ca2+-dependent signaling events, independently
from excitation contraction coupling.
Results and Discussion
ORAI1 is expressed in the mouse heart in vivo
Immunohistochemistry of mice hearts at different stages showed
ubiquitous ORAI1 expression in embryonic tissues, including the
heart (Fig. 1A) (Gwack et al., 2008; Vig et al., 2008). Orai1
mRNA expression was largely decreased at 2 months compared
with 2 days after birth (supplementary material Fig. S1A). In
adult hearts, ORAI1 localized to the plasma membrane of
cardiomyocytes and was highly expressed in the vasculature
(Fig. 1B). In addition, ORAI1 was detected using a proximity
ligation assay in adult hearts (Fig. 1C) as well as in isolated adult
cardiomyocytes (supplementary material Fig. S2C), suggesting
that ORAI1 is expressed throughout development and in adult
cardiomyocytes.
Identification and expression of the zebrafish
ORAI1 orthologue
To evaluate the role of ORAI1 in cardiac function in zebrafish,
we identified the zebrafish orthologue (zOrai1 for zebrafish
Orai1), which shows high evolutionary conservation to the
mouse (77%) and human (76%) proteins (supplementary



















we detected zorai1 transcripts ubiquitously in various tissues,
including heart, throughout development (Gwack et al., 2008;
Vig et al., 2008). At 24 hours postfertilization (hpf), zorai1 was
expressed ubiquitously (not shown). By 48 hpf, zorai1
expression was more restricted, with pronounced expression in
brain, liver, somites and heart (Fig. 1D). This pattern was
maintained at 72 hpf, with diminishing expression in somites
(Fig. 1E).
Fig. 1. Orai1 expression in mice and zebrafish and consequences of ORAI1 knockdown. (A–C) Representative immunostaining with antibodies against
tropomyosin (green), ORAI1 (red) and nuclei (Sytox Blue) show ORAI1 expression in mouse cardiomyocytes at 11 days postcoitum (A) and 2 months after birth
(B). (C) Proximity ligation assay confirmed ORAI1 expression in the adult mouse heart in vivo. Note that one red dot represents one ORAI1 protein complex.
(D,E) In situ hybridization of orai1 (zorai1) in zebrafish at 48 (D) and 72 (E) hpf shows high expression in brain (b), heart (h; and inset in D), somites (s) and liver
(l; inset in E). (F–I) MO-ORAI1-injected embryos display characteristics of cardiac dysfunction at 48 hpf that had progressed at 72 hpf (H,I) and was not seen in
controls (F,G): diminished blood flow and pericardial edema and blood congestion at the sinus venosus (arrow). (J,K) Ventricular fractional shortening (FS; J) and
heart rate (K) in control and MO-ORAI1-injected embryos. Values are means ± s.d.; *P,0.05, n$10. (L–O) Immunostaining for atrium- and ventricle-specific
myosin heavy chains (MF20 and S46, respectively) show that these are expressed normally in ORAI1-deficient (M,O) embryos; (L,N) controls.


















Orai1 is required for proper heart and skeletal
muscle function
Next, we inactivated Orai1 by injecting morpholino-modified
antisense oligonucleotides targeting the splice donor site of exon
1 (MO-ORAI1) or the translational start site (MO-ORAI1ATG)
into one-cell zebrafish embryos (supplementary material Fig.
S1C). Identical phenotypes were obtained with both morpholino
oligonucleotides, whereas embryos injected with a control
oligonucleotide developed normally. MO-ORAI1-injected
embryos were indistinguishable from controls on day 1 of
development. By 48 hpf, Orai1-deficient embryos developed
severe heart failure, decreased blood circulation and blood
congestion at the inflow tract (Fig. 1F–I; supplementary material
Movie 1), and most failed to hatch, indicating reduced skeletal
muscle force generation. Ventricular contractility, determined by
ventricular fractional shortening, was reduced at 48 hpf and
further reduced at 72 hpf (Fig. 1J; supplementary material Movie
2). Orai1-deficient embryos developed severe bradycardia by 48
hpf overlapping with onset of reduced contractility (Fig. 1K).
Maturation of chamber myocardium proceeded normally with
proper growth of ventricular myocardium, and atrial and
ventricular cardiomyocytes expressing myosin heavy chains in
the regular chamber-specific pattern (Fig. 1L–O; supplementary
material Fig. S2B). Furthermore, Orai1-depleted hearts properly
expressed cardiac marker genes (supplementary material Fig.
S2A). Hence, ORAI1 deficiency caused severe heart failure,
bradycardia and skeletal muscle weakness without affecting early
cardiogenesis and cardiomyocyte differentiation.
In mice, ORAI1-deficiency causes muscle weakness (Gwack
et al., 2008; Vig et al., 2008) and perinatal death, probably
from myopathy. Mice lacking STIM1, the calcium sensor of
the endoplasmic and sarcoplasmic reticulum required to
activate ORAI1, also develop skeletal myopathy and severe
immunodeficiency, suggesting that CRAC signaling is essential
for normal muscle function (Stiber et al., 2008). All humans with
ORAI1 mutations have skeletal myopathy and usually die from
severe immunodeficiency and lethal infections by 1 year of age
(Feske et al., 2006; McCarl et al., 2009). No assessment of
cardiac performance in such patients has been reported so far. We
demonstrate for the first time that loss of ORAI1 causes heart
failure, without affecting initial myocyte differentiation.
Loss of zebrafish Orai1 leads to loss of skeletal and
cardiac muscle integrity
Many skeletal myopathies cause structural and ultrastructural
abnormalities in myocytes. We determined whether skeletal
muscle weakness in Orai1-deficient embryos reflected altered
muscle organization. Immunofluorescence analysis of MO-
ORAI1-injected embryos revealed frequent disruption of
myofilaments and detachment of myofibrils from myosepta at
48 hpf, with increased severity at 72 hpf, leading to myofiber-free
spaces in somites, similar to that seen in mutants deficient for
dystrophin–glycoprotein-complex-associated proteins or integrin-
linked kinase (Cheng et al., 2006; Guyon et al., 2005; Postel et al.,
2008) (Fig. 2A–D). Additionally, at 72 hpf, myofiber density
within the somites appeared to be reduced.
Detachment of myofibers is often accompanied by loss of
myoseptal integrity (Etard et al., 2010; Parsons et al., 2002;
Postel et al., 2008). To evaluate whether loss of Orai1 function
affects myoseptal integrity, we performed immunostaining
against vinculin, an adaptor protein linking muscle fibres,
through integrins, to the extracellular matrix (Critchley, 2000;
Postel et al., 2008). At 48 hpf, vinculin level was reduced in
myosepta of Orai1-deficient embryos, and vinculin localization at
the somite boundaries was disturbed and present ectopically in
somites (Fig. 2E,F), indicative for loss of myoseptal integrity
(Etard et al., 2010; Postel et al., 2008). At 72 hpf, a stage with
advanced myofiber disruption, vinculin levels further declined
and mislocalization increased in Orai1-deficient skeletal muscle.
Myosepta frequently appeared as tattered, blurry stripes rather
than distinct, thin lines separating adjacent somites, as in
controls. Thus, loss of Orai1 in zebrafish caused progressive
disruption of myofibers and loss of myoseptal integrity,
suggesting that Orai1 function is not required for initial muscle
assembly but essential for maintaining and straightening of
muscle structure. The decreasing myofiber density in somites at
72 hpf suggests that reduced Orai1 disturbs muscle fiber growth
and thereby adaptation of muscle force to higher demands during
development.
To elucidate the mechanism that effects muscle integrity, we
analyzed the ultrastructure of skeletal muscle cells in MO-
ORAI1-injected embryos. At 72 hpf, myofibrils in controls were
densely packed with precisely aligned and highly organized thick
and thin filaments delimited by well-defined z-discs (Fig. 2I). By
contrast, even though organized sarcomeric units were generally
present, the myofibrils appeared thin and instead of being densely
packed, individual myofibrils were separated by cytoplasm
(Fig. 2J). Frequently, myofibrils changed from being well
organized to disorganized within one to two sarcomeric units,
with progressively dispersing thin and thick filaments (Fig. 2J).
Additionally, instead of the well-contrasted and distinct z-discs
seen in control embryos, the z-lines in MO-ORAI1-injected
skeletal muscle cells appeared faint.
To our knowledge, ORAI1-deficient myocytes have not been
thoroughly analyzed. Consistent with loss of ORAI1,
ultrastructural evaluation of STIM1-deficient skeletal muscle
similarly showed muscle atrophy (Stiber et al., 2008).
Additionally, we found that Orai1 inactivation caused
abnormalities of myofibril organization and of the z-line in
skeletal and cardiac muscle in zebrafish, characteristics not
described for STIM1-deficient mice.
We speculated that defects similar to those in skeletal muscle
cells might explain the decreased contractility in Orai1-
deficient hearts. Cardiomyocytes from MO-ORAI1-injected
embryos similarly had fewer, thinner myofibrils than control
cardiomyocyte (Fig. 2K,L). The z-discs between sarcomeres in
Orai1-deficient cardiomyocytes were stretched, blurry and often
seemingly absent. Thus, Orai1 deficiency induces similar defects
in skeletal and cardiac myocytes.
The fact that correctly assembled, although thinner and less
densely packed, sarcomeres were present in both skeletal and
cardiac tissues suggests that Orai1 loss does not impair initial
sarcomerogenesis but disrupts myofibril growth, possibly
limiting adaptation of muscle force to increasing demands
during development. Our data on vinculin, as well as the
aggravation of myofiber disruption, further suggests that ORAI1-
deficiency affects sarcomere stability in part by altering the
integrity of adhesion complexes linking muscle fibers through
adaptor proteins to the extracellular matrix. Because z-discs are
crucial for sarcomere stability, the abnormalities in Orai1-
deficient skeletal and cardiac z-discs might contribute to the
instability and disaggregation of myofibrils (Hassel et al., 2009).


















Fig. 2. Consequences of ORAI1-deficiency on skeletal and cardiac muscle. (A–D) Immunostaining with anti-myosin (MF20) reveals progressive myofilament
disorganization and frequent detachment of myofibrils from the myosepta (bold arrow) in Orai1-deficient zebrafish embryos at 48 (B) and 72 (D) hpf, compared
with controls (A,C). (E–H) Immunofluorescent staining for vinculin reveals disturbed somite boundaries and diminished expression and mislocalization (arrow) in
Orai1-deficient embryos at 48 (F) and 72 (H) hpf compared with controls (E,G). (I–L) Transmission electron micrographs of MO-ORAI1-injected embryos at 72
hpf reveal fewer and thinner myofibrils in skeletal muscle cells (J) than in control muscle (I). Myofibrils often collapsed gradually (bold arrow in J). Z-discs often
appeared to be missing (arrow). Ultrastructural analysis in Orai1-deficient cardiomyocytes (L) and control cells (K) similarly revealed fewer and thinner
sarcomeres flanked by stretched and barely noticeably z-lines (arrows in L). Cross sections through cardiac sarcomeres displayed normal primary organization of
thick and thin filaments in hexagonal lattices (insets in K and L). Scale bars: 1 mm.


















Fig. 3. Loss of ORAI1 signaling in cardiomyocytes leads to impaired calsarcin localization and defective stretch sensing. (A) Immunostaining of mouse
cardiomyocytes with anti-actinin (green) and anti-calsarcin shows z-disc localization of calsarcin in control cardiomyocytes and severe sarcomeric disorganization
and growth defects in ORAI1-deficient cardiomyocytes with absence of calsarcin at the z-disc. Insets show higher magnification. (B) Representative western blot
and quantification of calsarcin expression after ORAI1 knockdown in cardiomyocytes. (C) Nuclear localization of NFAT was analyzed using a EGFP–NFAT
adenovirus. After treatment with phenylephrine (PE) more than 60% of the cells showed nuclear localization of NFAT, whereas ORAI1 KD prevented the nuclear
localization of NFAT (n52 experiments; *P,0.05). White arrows indicate cells with nuclear localization of NFAT. (D) Immunostaining against ANP
shows fewer ANP-positive nuclei after ORAI1 KD. Cells were treated for 25 hours with phenylephrine. (E) RT-PCR shows that the induction of the ‘fetal gene
program’ (ANP and BNP) is blunted after ORAI KD. Cells were treated for 24 hours with phenylephrine (n52 experiments; *P,0.05). (F–I) RNA levels
of the stretch-responsive gene anf are elevated in MO-ORAI1-injected zebrafish embryos. Compared with the expression of anf in control hearts at 48 (F) and 72
(H) hpf, anf expression in ORAI1-deficient hearts was upregulated at 48 (G) and 72 (I) hpf.


















Loss of ORAI1 impairs expression and localization of
calcium-dependent signaling components
in cardiomyocytes
Phenylephrine-induced hypertrophic growth of neonatal rat
ventricular cardiomyocytes (NRCM) represents an excellent
model to study myofibril addition and sarcomere growth in
vitro. To test our hypothesis that ORAI1 is necessary for
sarcomeric growth, we decreased ORAI1 expression in neonatal
rat ventricular cardiomyocytes with ORAI1-specific short
interfering RNA (siRNA). At 48 hours after transfection,
ORAI1 expression was reduced by 61% (supplementary
material Fig. S3A,B). Treatment with phenylephrine increased
cell surface area 2.3-fold at 24 hours together with a remarkable
organization and growth of the sarcomeric structure
(supplementary material Fig. S3C,D). However, siOrai1-treated
cells failed to organize sarcomeres and hypertrophic growth was
considerably attenuated (1.4-fold increase of the cell surface area
over baseline).
Next, we analyzed the z-disc structure of neonatal
cardiomyocytes by immunostaining for actinin and calsarcin.
ORAI1 is implicated in regulating calcium–calcineurin–NFAT
signaling. Calcineurin binds to calsarcins, a family of striated
muscle-specific proteins located at the sarcomeric z-disc, and
calsarcin-deficiency results in z-disc remodeling (Frank et al.,
2007). In siOrai1-transfected cardiomyocytes, sarcomeres were
thinner and less organized than in controls (Fig. 3A).
Interestingly, calsarcin failed to localize to z-discs, and global
calsarcin expression was decreased (Fig. 3A,B). These findings
support our in vivo data in that the Ca2+ entry through the ORAI1
channel is essential for proper sarcomeric growth and function in
cardiomyocytes, and furthermore indicate that ORAI1 is required
for localization of the calcineurin–NFAT signaling component
calsarcin to the cardiac z-disc. This finding is supported by the
notion that analysis of the nuclear localization of NFAT using an
EGFP–NFAT adenovirus is prevented by ORAI1 knockdown
(KD; Fig. 3C). In addition the induction of the ‘fetal gene
program’ is blunted in ORAI1 KD cardiomyocytes (Fig. 3D,E).
Calsarcin depletion was previously shown to result in the
activation of calcineurin–NFAT-mediated hypertrophic gene
transcription (Frey et al., 2004). Because calsarcin inhibits
calcineurin signaling, global downregulation of calsarcin might
represent a compensatory attempt to restore defective calcineurin
signaling after ORAI1 knockdown in vivo. Importantly, calsarcin
interacts with important components of the z-disc, including
telethonin (also known as T-Cap), Cypher (ZASP) and myotilin,
all of which can cause cardiomyopathy or muscular dystrophy
when dysfunctional, highlighting the importance of calsarcin–
calcineurin–NFAT regulation by ORAI1 (Frank et al., 2006;
Hayashi et al., 2004; Moreira et al., 2000; Olive et al., 2005;
Selcen and Engel, 2005; Vatta et al., 2003). Further analysis in
adult cardiomyocytes lacking ORAI1 are needed to determine the
molecular mechanism in more detail, but are hindered by the
perinatal death of ORAI1-deficient mice (Gwack et al., 2008).
ORAI1-deficient cardiomyocytes develop disturbed
stretch sensing
Besides cross-linking thin filaments and stabilizing sarcomeres
by transmission of force generated during contraction, z-discs
are nodal points for mechanotransduction (i.e. stretch sensing)
(Frank et al., 2006). Given the ultrastructural abnormalities
and mislocalization of calsarcin (an important Ca2+-signaling
component) in ORAI1-deficient z-discs, we hypothesized that
ORAI1 is required to establish a functioning, properly signal-
transducing z-disc. Therefore, we assessed expression of the
stretch-responsive gene encoding atrial natriuretic factor (anf) by
whole-mount RNA in situ hybridization (Bendig et al., 2006). At
48 hpf anf was markedly upregulated, and still slightly increased
at 72hpf (Fig. 3F–I), indicative of cardiac dysfunction and
impaired stretch sensing in zebrafish (Bendig et al., 2006).
Calcineurin interacts directly with the mechanosignaling
transduction protein muscle-LIM-protein (MLP), and calsarcin
and calcineurin are displaced from the z-disc upon MLP
depletion (Heineke et al., 2005). Animals lacking calcineurin or
calsarcin express higher levels of Anf, endorsing our data in
zebrafish (Frey et al., 2004; Schaeffer et al., 2009).
ORAI1 expression is increased in response to
cardiac damage
Our results show that ORAI1 is necessary for muscle growth and
physiological adaptation to increasing performance requirements.
To determine whether ORAI1 signaling contributes to
pathological aspects of hypertrophy, we analyzed ORAI1
expression in mice after myocardial infarction or transaortic
constriction (TAC) to induce pressure overload-mediated
Fig. 4. Upregulation of ORAI1 expression after
pathological challenge in mice. (A–C) Orai1 mRNA level
(A) and protein expression (B,C) have increased 4 days after
TAC. (D–F) Orai1 mRNA (D) and protein (E,F) levels are
increased 4 days after myocardial infarction (*P,0.05).


















hypertrophy. Sham-operated mice served as controls. After TAC,
ORAI1 protein and mRNA increased significantly (P,0.001;
Fig. 4A–C) and the fetal gene program was reactivated (data not
shown). ORAI1 expression also increased after myocardial
infarction (Fig. 4D–F). Thus, ORAI1 might contribute to the
pathology of hypertrophy, even in humans, although the
molecular mechanism is unknown.
In summary, we confirmed that loss of Orai1 causes skeletal
muscle weakness in zebrafish (Gwack et al., 2008; McCarl et al.,
2009). Structural and ultrastructural analysis revealed that the
weakness is due to myofibrillar disruption and progressive
mechanical instability in skeletal myocytes, both distinctive
features of muscular dystrophy in humans and zebrafish (Emery,
2002; Postel et al., 2008). Furthermore, we show, for the first
time, that Orai1 deficiency in zebrafish causes heart failure.
Sarcomeres in Orai1-deficient hearts exhibit lateral growth and
ultrastructural abnormalities at the cardiac z-disc with decreased
expression and displacement of calsarcin from the z-disc. Loss of
Orai1 also caused defective signal transduction at the cardiac
z-disc. Our findings link ORAI1-mediated calcium signaling to
sarcomere physiology, in part by affecting z-disc composition
and function mediated by the calcineurin-calsarcin-NFAT
signaling pathway. Thus, the molecular machinery mediating
SOCE might represent a valuable pharmacological target to
modulate Ca2+-dependent signaling to improve the outcome of
pathological cardiac hypertrophy.
Materials and Methods
Zebrafish care and breeding, injection procedures and functional analysis
Care and breeding of zebrafish (Danio rerio) was carried out as previously described
(Westerfield, 1995). Morpholino-modified antisense oligonucleotides were designed
against the translational start site of zebrafish ORAI1 [NM_205600] (MO-
ORAI1ATG 59-AGTGCTCGCTCCGACTCATCTTCAT-39) and the splice donor
site of zebrafish ORAI1 exon 1 (MO-ORAI1 59-AAACAGCGCGGAGACTC-
ACCATTGC-39). Functional assessment of cardiac contractility was carried out
essentially as described previously (Rottbauer et al., 2005).
Myocardial infarction and transaortic constriction
Surgical procedures on mice have been described previously (Muraski et al.,
2007). Briefly, myocardial infarction was produced by ligating the left anterior
descending coronary artery with an 8-0 suture (Ethicon). For trans-aortic
constriction (TAC), the aorta was ligated between the innominate artery and the
left common carotid artery by using a 7-0 polypropylene suture (Ethicon) with an
overlying 27-gauge needle to produce a discrete stenosis. All animal experiments
were performed according to the relevant regulatory standards.
Whole-mount in situ hybridization, immunohistochemistry, histology and
transmission electron microscopy
Whole-mount in situ hybridization and immunofluorescence staining of zebrafish
embryos was carried out essentially as described previously (Hassel et al., 2009).
The following antibodies were used: MF20 (1:20; Developmental Studies
Hybridoma Bank, developed by D. A. Fishman) and anti-vinculin (1:50; Sigma).
72 hpf control and MO-ORAI1-injected embryos were used for histological
analysis of the heart. Histological sections were prepared as described previously
(Rottbauer et al., 2001). Transmission electron microscopy analysis was carried
out as described by Kurrasch et al. (Kurrasch et al., 2009).
Immunohistochemistry of mouse sections have been described before (Muraski
et al., 2007). In brief, hearts were flushed with formalin for 15 minutes, excised,
and fixed in formalin for 24 hours at room temperature. Sections were cut and
deparaffinized using standard procedures. Primary antibodies were applied
overnight at 4 C˚ in nitro blue tetrazolium. The Orai1 signal was detected with a
Tyramide Signal Amplification kit (Perkin Elmer), used according to the
manufacturer’s recommendations. To reveal nuclei, slides were treated with To-
pro3 iodide (Molecular Probes; 1:10,000) for 20 minutes in 16 TN (Tris-based
neutral buffer), washed, and a coverslip place on top. Micrographs were acquired
with a Leica TCS-SP2 confocal laser scanning microscope. Neonatal rat
ventricular cardiomyocytes (NRCMs) grown on glass coverslips were treated
with Orai1 or scrambled siRNA as described before (Voelkers et al., 2010). After
48 hours cells were fixed, permeabilized and stained using standard procedures. A
proximity ligation assay to detect ORAI1 was used. Blocking, staining,
hybridization, ligation, amplification and detection steps were performed
according to manufacturer’s instructions (OLINK).
Western blot analysis
Whole-cell lysates of hearts and NRCM lysates were prepared in 16 SDS sample
buffer and immunoblotted. Primary antibodies used were against GAPDH
(Invitrogen) and Orai1 (Santa Cruz Biotechnology). Calsarcin antibody was a
gift from Norbert Frey (Kiel, Germany). The day after application of the
antibodies, blots were washed three times with Tris-buffered saline plus 0.1%
Tween-20 (TBS-T), probed with fluorescent or alkaline phosphatase–conjugated
secondary antibodies (1:2000 in blocking solution; Jackson Immunoresearch
Laboratories) for 2 hours at room temperature, washed three times with TBS-T,
and scanned.
Isolation and primary culture of neonatal and adult
ventricular cardiomyocytes
Ventricular cardiomyocytes from 1- to 2-day-old rat neonatal hearts (NRCMs)
were prepared by trypsin digestion as described previously (Voelkers et al., 2010).
Adult ventricular cardiomyocytes were isolated using standard procedures as
previously described (Most et al., 2006). In a subset of experiments NRCMs
transfected with the siRNAs were transfected on the same day with an EGFP–
NFAT adenovirus and the cellular localization of EGFP–NFAT were analyzed
48 hours after transfection and 24 hours after treatment with phenylephrine.
RNA interference
Custom-designed synthetic orai1 siRNA and scrambled siRNA as a negative
control were from Applied Biosystems. NRCMs were transfected with orai1 and
control siRNA oligonucleotides (25 nM) by using HiPerfect transfection reagent
according to the manufacturer’s instructions (Qiagen).
RNA isolation, reverse transcription and quantitative real-time PCR
Total RNA was isolated from frozen heart or cultured cells with Quick-RNA
MiniPrep (Zymo Research) and reverse-transcribed into cDNA with an
iScriptcDNA Synthesis kit (Bio-Rad). Real-time PCR was performed on all
samples in triplicate with a QuantiTect SYBR Green PCR kit (Qiagen) according
to the manufacturer’s instructions. All primer sequences are shown supplementary
material Table S1.
For RT-PCR analysis, total RNA from hearts derived from control and MO-
orai1-injected embryos at 72 hpf was extracted using Trizol reagent (Invitrogen).
RNA was subsequently treated with DNase and reverse transcribed using a random
hexamer primer and SuperScript II reverse transcriptase (Invitrogen). Gene-
specific primer sequences are available upon request. Amplification involved 35–
40 cycles. Elongation factor I alpha (elfa) was used as endogenous control
(McCurley and Callard, 2008).
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